JaypeeDigital | eBook Reader

Fun with Dermatology Sanjiv Jain

1:Impetigo
- DESCRIPTION
  - Systems affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
  - Impetigo contagiosa
  - Bullous impetigo
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
  - Bullous impetigo
  - Non bullous impetigo
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Systemic
  - Topical
  - Contraindications
  - Precautions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
2:Staphylococcal Folliculitis
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSES
- RISK FACTORS
  - Clinical Features
- LABORATORY
  - Drugs that may lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TEST
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
  - Face
  - Scalp
  - Trunk
  - Extremities
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Systemic
  - Topical
  - Contraindication
  - Precautions
  - Significant possible interaction
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATION
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Pediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
3:Furuncles and Carbuncles
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
  - Furuncles
  - Carbuncle
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGIC FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Systemic antibiotics
  - Contraindication
  - Precautions
  - Significant possible interactions
- OTHER MEASURES
- PATIENT MONITORING
- PREVENTION/AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Pediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
4:Herpes Simplex
- INTRODUCTION
  - HSV-1 infections include
  - HSV-2 infection
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
  - Primary disease
  - Recurrent diseases from reactivation
- CAUSES
- ETIOPATHOGENESIS
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TEST
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interactions
  - Others
- ALTERNATIVE MEDICATIONS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Pediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
5:Herpes Zoster
- DESCRIPTION
  - Systems affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
  - Prodromal phase (pre- eruptive phase)
  - Acute eruptive phase
  - Chronic phase
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab re sults
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
  - Rash
  - Pain
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significnat possible interaction
- ALTERNATIVE DRUGS AND MANAGEMENT
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELEASED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
6:Warts
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Common warts
  - Filiform warts
  - Plane warts
  - Condylomata acuminata
  - Plantar warts
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION/AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHERS NOTES
- ABBREVIATIONS
7:Molluscum Contagiosum
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- TREATMENT OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interaction
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
8:Pityriasis Versicolor
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATION
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
9:Dermatophyte (Ringworm) Infections
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
  - Tinea capitis
  - Tinea barbae
  - Tinea corporis (tinea gla brosa)
  - Tinea cruris
  - Tinea pedis
  - Tinea manuum
  - Onychomycosis (Tinea unguium)
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
  - Imaging
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
  - Tinea capitis
  - Tinea barbae
  - Tinea corporis
  - Tinea cruris
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Topical therapy
  - Systemic therapy
  - Adults
  - Skin infection
  - Hair and scalp infections
  - Onychomycosis
  - Cream
  - Contraindications
  - Precautions
  - Significant possible interaction
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED CONDITIONS
  - Pediatric
  - Geriatic
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
10:Candidosis
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SINGS AND SYMPTOMS
- RISK FACTORS
  - Physiological factors
  - Local factors
  - Acquired factors
  - Debilitating diseases
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
  - Oropharyngeal candidosis
  - Angular cheilitis
  - Vaginal candidosis
  - Candidal intertrigo
  - Candidal infection of the nails
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Oral candidosis
  - Vaginal candidosis
  - Candidal balanitis
  - Candidal intertrigo
  - Candidal paronychia
  - Contraindications
  - Precautions
  - Significant possible interactions
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
11:Syphilis
- DESCRIPTION
  - Early acquired syphilis
  - Late acquired syphilis
  - Congenital syphilis
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS EARLY SYPHILIS
  - Primary acquired syphilis
  - Infectious syphilis— secondary syphilis
- LATENT SYPHILIS
- LATE SYPHILIS
  - Late mucocutaneous syphilis
- CARDIOVASCULAR SYPHILIS
- NEUROSYPHILIS
- CONGENITAL SYPHILIS
  - Early congenital syphilis
- LATE CONGENITAL SYPHILIS
- CAUSE(S)
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Nonspecific treponemal tests
  - Specific temponemal tests
  - Others
    - Cerebral fluid examination
- APPLICATION OF TESTS
  - Primary acquired syphilis
  - Secondary acquired syphilis
  - Tertiary syphilis
  - Neurosyphilis
  - Congenital syphilis
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURE
- DIFFERENTIAL DIAGNOSIS
  - Stage of Disease
- APPOPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Early syphilis
  - Late syphilis (excluding neurosyphilis)
  - Neurosyphilis
  - Congenital syphilis
  - Abnormal cerebrospinal fluid
  - Normal cerebrospinal fluid examination
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
  - Retreatment
- PREVENTION / AVOIDANCE
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
12:Chancroid
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSE(S)
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significnat possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
13:Lymphogranuloma Venereum
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
  - Primary
  - Secondary
  - Tertiary
- CAUSE(S)
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
14:Granuloma Inguinale (Donovanosis)
- DESCRIPTION
  - System affected
  - Genetics
  - Predominant sex
  - Predominant age
- SIGNS AND SYMPTOMS
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
15:Gonorrhoea
- DESCRIPTION
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
  - Urethritis
    - Males
    - Females
  - Gonococcal proctitis
  - Pharyngeal gonorrhoea
  - Pelvic inflammatory disease
  - Disseminated gonococcal infection
- CAUSES
- RISK FACTORS
- Clinical FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Uncomplicated genital and anal infections
  - Pharyngeal infection
  - Disseminated infection
  - Ophthalmia neonatorum
  - Prevention of ophthalmia neonatorum
  - Contraindications
  - Precaution
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEEL ALSO
- OTHER NOTES
- ABBREVIATIONS
16:Non-Gonococcal Urethritis
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Preominant sex
- SIGNS AND SYMPTOMS
  - Non-gonococcal urethritis
    - Males
    - Females
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
17:HIV and the Acquired Immunodeficiency Syndrome
- INTRODUCTION
  - Category A
  - Category B
  - Category C (AIDS-defining conditions)
  - Primary HIV infection
  - Asymptomatic HIV infection (early-stage disease, CD4+ > 500 cells/mm3)
  - Early symptomatic HIV disease (CD4+ 200-500/mm3)
  - Late symptomatic HIV disease (CD4+ 50-200/mm3)
  - Advanced HIV disease (CD4+ count <; 50 cells/mm3)
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
  - Infections/infestations
  - Bacterial infections
    - Mycobacterium spp.
  - Viral infections
  - Fungal infections
  - Deep infection
  - Infestations
  - Non-infectious manifestations
  - Cutaneous malignancies
  - Cutaneous lymphomas
  - Poorly classified skin eruptions
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
- PATIENT MONITORING
- PREVENTION/AVOIDANCE
  - Blood products
  - Health care workers
  - Perinatal transmission
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Pediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
18:Cutaneous Tuberculosis
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
  - Tuberculous chancre
  - Miliary tuberculosis
  - Lupus vulgaris (LV)
  - Tuberculosis verrucosa cutis (TBVC)
  - Scrofuloderma (tuberculosis colliquitiva cutes)
  - Tuberculosis cutis orificialis (TBCO)
- CAUSE(S)
- RISK FACTORS
- ETIOPATHOGENESIS
- CLINICAL FEATURES
  - Relative criteria
  - Absolute criteria
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- SPECIAL TESTS
- SKIAGRAM
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interactions
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNO SIS
- Associated conditions
  - Tuberculids
  - Atypical mycobacteriosis
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHERS NOTES
- ABBREVIATIONS
19:Leprosy
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSES
  - Tuberculoid tuberculoid (TT)
  - Borderline tuberculoid (BT)
  - Borderline borderline (BB)
  - Borderline lepromatous (BL)
  - Lepromatous leprosy
- Causes
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
  - Borderline leprosy
  - Lepromatous leprosy (LL)
- SPECIAL TEST
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
  - TT
  - LL
  - Borderline Leprosy
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Lepra reactions
  - Contraindications
  - Precautions and side effects
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- Expected course and prognosis
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
20:Acne Vulgaris
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGN AND SYMPTOMS
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Systemic therapy
    - Antibiotics
  - Mild Acne (Open and Closed Comedones)
  - Mild to Moderate Acne
  - Moderate to Severe Acne
  - Nodulocystic acne
  - Contraindication
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
21:Rosacea
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
  - Prerosacea
  - Vascular rosacea
  - Inflammatory Rosacea
  - Late Rosacea
  - Complications
- CAUSE(S)
- PATHOGENESIS
- CLINICAL FEATURES
- LABORATORY
  - Drug that may alter lab results
  - Disorders that may alter lab results
- DIFFERENTIAL DIAGNOSIS
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Topical Medications
  - Systemic Medications
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION/AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
22:Perioral Dermatitis
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSE(S)
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TEST
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
23:Vitiligo
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSE(S)
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG (S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
24:Atopic Dermatitis
- DESCRIPTION
  - Genetics
  - Predominant age
  - Predominant sex
  - Incidence and prevalence
  - Racial, social and regional variations
- SIGNS AND SYMPTOMS
  - Infantile phase
  - Childhood phase
  - Adolescent and young adult phase
  - Adult phase
  - Xerosis
  - Ichthyosis, palmar hyperlinearity, and keratosis pilaris
  - Cheilitis
  - Nipple eczema
  - Non-specific hand and foot dermatitis
  - Elevated serum IgE
  - Immediate type 1 skin test reactivity
  - Pityriasis alba
  - Tendency towards cutaneous infections
  - Anterior neck folds
  - Itch when sweating
  - Intolerance to wool
  - Food intolerance
  - Course influenced by environmental factors
  - Abnormal vascular reactivity
  - Reticulate pigmentation
  - Periauricular fissures
  - Ocular changes
- PATHOGENESIS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUGS OF CHOICE
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
25:Seborrhoeic Dermatitis
- DESCRIPTION
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
  - Scalp
  - Groin
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Scalp
  - Face
  - Chest/back
  - Eyelids
  - Skin folds
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION /AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
26:Lichen Simplex Chronicus
- INTRODUCTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TEST
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Topical
  - Systemic
- ALTERNATIVE DRUGS
  - Contraindications
  - Precautions
  - Significant possible interactions
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Pediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
27:Nummular Dermatitis
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSE(S)
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interactions
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
28:Scabies
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- ETIOLOGY
- PATHOGENESIS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
- TREATMENT OF SPECIAL VARIANTS
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEEL ALSO
- OTHER NOTES
- ABBREVIATIONS
29:Pemphigus
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
  - Pemphigus vulgaris
  - Pemphigus vegetans
  - Pemphigus foliaceous
  - Pemphigus erythematosus
- CAUSE(S)
- ETIOPATHOGENESIS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interaction
- ALTERNATIVE DRUGS
  - Phase I
  - Phase II
  - Phase III
  - Phase IV
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXEPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
30:Pemphigoid
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
31:Dermatitis Herpetiformis
- DESCRIPTION
  - Systems affected
  - Genetics
  - Prominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- OTHER TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- DIET
- ACTIVITY
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
32:Ichthyosis
- Description
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGIC FINDINGS
- SPECIAL TESTS
- DIAGNOSTIC PROCEDURES
- IMAGING
- PRENATAL DIAGNOSIS
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENTS EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITION
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBERVIATIONS
33:Epidermolysis Bullosa
- Description
- CLASSIFICATION
  - Epidermolysis bullosa simplex
  - Junctional epidermolysis bullosa
  - Dystrophic epidermolysis bullosa
  - System(s) affected
  - Predominant age
- SIGNS AND SYMPTOMS
  - Epidermolysis bullosa of the hands and feet (Weber cockayne variant)
  - Generalized epidermolysis bullosa simplex (Koebner)
  - Generalized junctional epidermolysis bullosa (gravis, herlitz or letalis)
  - Dominant dystrophic epidermolysis bullosa
  - Recessive dystrophic epi dermolysis bullosa, gravis (Hallopeau—Siemens)
  - Recessive dystrophic epider molysis bullosa (mitis)
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
  - Epidermolysis bullosa simplex
  - Junctional epidermolysis bullosa
  - Dominant dystrophic epidermolysis bullosa
  - Recessive dystrophic epidermolysis bullosa
- ELECTRON MICROSCOPY
  - Epidermal EB
  - Junctional EB
  - Dominant dystrophic EB
  - Recessive dystrophic EB
- SPECIAL TEST
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interaction
- OTHER THERAPIES
- PATIENTS MONITORING
- PREVENTIVE / POSSIBLE AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
34:Pityriasis Rosea
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- DIFFERENTIAL DIAGNOSIS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significnat possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHERS NOTES
- ABBREVIATIONS
35:Lichen Planus
- Description
  - System (s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
  - Skin
  - Mucous membranes
  - Nails
  - Hairs
  - Clinical variants of lichen planus
- CAUSE(S)
- RISK FACTOR(S)
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Skin
  - Mucous membranes
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHERS NOTES
- ABBREVIATIONS
36:Psoriasis
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- Signs and Symptoms
- CAUSES
  - Genetic
  - Immunopathogenesis
  - Epidermal hyperproliferation
  - Vascular proliferation
  - Conclusion
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
  - Psoriasis vulgaris
  - Guttate psoriasis
  - Flexural psoriasis
  - Nail psoriasis
  - Erythrodermic psoriasis
  - Palmoplantar pustulosis
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Mild disease
  - Severe disease
  - Contraindications
  - Precautions
    - MTX
  - Significant possible interactions
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
- Others
- PREGNANCY
- SYNONYM
- OTHER NOTES
- ABBREVIATIONS
37:Alopecia Areata
- DESCRIPTION
  - Systems affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE-RELATED FACTORS
  - Paediatric
  - Geriatric
  - Other
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHERS NOTES
- ABBREVIATIONS
38:Telogen Effluvium
- DESCRIPTION
  - System(s) affected
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- OFFICE PROCEDURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TEST
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Other
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
39:Patterned Alopecia (Androgenic Alopecia)
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSES
- PATHOGENESIS
- RISK FACTORS
- CLINICAL FEATURES
  - Men
  - Women
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TESTS
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interaction
- ALTERNATIVE DRUGS
- ALTERNATIVE MEASURES
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
40:Benign Tumours, Moles, Birthmarks, and Cysts
- TUMOURS OF EPIDERMAL ORIGIN
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- MISCELLANEOUS
- BENIGN TUMOURS OF SWEAT GLAND ORIGIN (ECCRINE AND APOCRINE DIFFERENTIATION)
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- DIAGNOSIS
- TREATMENT
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- BENIGN MELANOCYTIC TUMOURS
- DIAGNOSIS
- TREATMENT
- DESCRIPTION
- Diagnosis
- Treatment
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- BENIGN TUMOURS COMPOSED OF EPIDERMAL MELANOCYTES
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- VASCULAR NAEVI
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- DIAGNOSIS
- TREATMENT
- DESCRIPTION
- DIAGNOSIS
- TREATMENT
- Description
41:Malignant Tumours of the Skin (Nonmelanoma Skin Cancer)
- DESCRIPTION
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSES
- DIFFERENTIAL DIAGNOSIS
- SPECIFIC INTERVENTIONS
- DESCRIPTION
- SIGNS AND SYMPTOMS
- CAUSES
- DESCRIPTION
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSES
- DESCRIPTION
- SIGNS AND SYMPTOMS
- DESCRIPTION
- SIGNS AND SYMPTOMS
- CAUSES
42:Urticaria
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
  - Immune mediated urticaria
    - IgE dependent
    - Non IgE dependent
  - Primary urticariogenic substances
  - Physical urticaria
- CAUSES
- PATHOGENESIS
- CLINICAL FEATURES
  - Acute urticaria
    - History
    - Physical examination
  - Chronic urticaria
    - History
    - Physical examination
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TEST
- IMAGING
- DIAGNOSTIC PROCEDURES
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUGS OF CHOICE
  - Nonsedating histamine H1-antagonists
  - Astemizole
  - Cetirizine
  - Terfenadine
  - Loratadine
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PATIENT MONITORING
- PREVENTION/AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE-RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
43:Discoid Lupus Erythematosus
- DESCRIPTION
  - System(s) affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
- CAUSES
- RISK FACTORS
- CLINICAL FEATURES
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TEST
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUG(S)
- PATIENT MONITORING
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
44:Systemic Lupus Erythematosus
- DESCRIPTION
  - System affected
  - Genetics
  - Predominant age
  - Predominant sex
- SIGNS AND SYMPTOMS
  - Mucocutaneous lesions
  - Vascular lesions
  - Cardiovascular manifestations
  - Musculoskeletal manifestations
  - Hematologic manifestations
  - Gastrointestinal manifestations
  - Neuropsychiatric manifestations
  - Nervous system involvement
  - Renal involvement
- CAUSES
  - Etiology
  - Pathogenesis
- RISK FACTORS
- LABORATORY
  - Drugs that may alter lab results
  - Disorders that may alter lab results
- PATHOLOGICAL FINDINGS
- SPECIAL TEST
- IMAGING
- DIAGNOSTIC PROCEDURES
- DIFFERENTIAL DIAGNOSIS
- APPROPRIATE HEALTH CARE
- GENERAL MEASURES
- ACTIVITY
- DIET
- PATIENT EDUCATION
- DRUG(S) OF CHOICE
  - Contraindications
  - Precautions
  - Significant possible interactions
- ALTERNATIVE DRUGS
- PREVENTION / AVOIDANCE
- POSSIBLE COMPLICATIONS
- EXPECTED COURSE AND PROGNOSIS
- ASSOCIATED CONDITIONS
- AGE RELATED FACTORS
  - Paediatric
  - Geriatric
  - Others
- PREGNANCY
- SYNONYMS
- SEE ALSO
- OTHER NOTES
- ABBREVIATIONS
Color Plates
- Plate 1
- Plate 2
- Plate 3
- Plate 4
- Plate 5
- Plate 6
- Plate 7
- Plate 8

INDEX

TOC
Index

×

Chapter Notes